Impact of non-alcoholic steatohepatitis (NASH) case definition on population characteristics identified in a US claims database

被引：0
|
作者：
Gallagher, Kerrin [1 ]
Esposito, Daina [1 ]
Jamal-Allial, Aziza A. [2 ]
Du, Simo [1 ]
Patel, Yuval [3 ]
Nguyen, Mindie [4 ]
Ness, Erik [5 ]
Capozza, Thomas [6 ]
Titievsky, Lina [5 ]
机构：
[1] HealthCore, Wilmington, DE USA
[2] HealthCore Inc, Wilmington, DE USA
[3] Duke Univ, Durham, NC 27706 USA
[4] Stanford Univ, Stanford, CA 94305 USA
[5] Intercept Pharmaceut, New York, NY USA
[6] Intercept Pharmaceut Inc, New York, NY USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2021年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：30 / 31
页数：2
相关论文
共 50 条
  • [1] Prevalence and Independent Predictors of Non-alcoholic Steatohepatitis (NASH) in the US Population
    Stepanova, Maria
    Mir, Heshaam
    Hallaji, Shareh
    Younossi, Youssef
    Srishord, Manirath
    Younossi, Zobair
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S132 - S132
  • [2] Non-alcoholic steatohepatitis (NASH)
    Michael F. Sorrell
    Sandeep Mukherjee
    Current Treatment Options in Gastroenterology, 1999, 2 (6) : 447 - 450
  • [3] Non-alcoholic Steatohepatitis (NASH) and alcoholic Steatohepatitis (ASH)
    Roeb, Elke
    DRUG RESEARCH, 2021, 71 : S16 - S18
  • [4] Sarcopenia in Non-alcoholic Steatohepatitis (NASH)
    Liu C.-H.
    Habig G.
    Smaltz C.
    Halegoua-DeMarzio D.
    Current Hepatology Reports, 2021, 20 (4) : 117 - 127
  • [5] Therapies in non-alcoholic steatohepatitis (NASH)
    Oseini, Abdul M.
    Sanyal, Arun J.
    LIVER INTERNATIONAL, 2017, 37 : 97 - 103
  • [6] Impact of Age and Gender on the Severity of Non-Alcoholic Steatohepatitis (NASH)
    Acharya, Eesha
    Lam, Robert
    Lim, Joseph
    Jain, Dhanpat
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 1106 - 1106
  • [7] Impact of Age and Gender on the Severity of Non-Alcoholic Steatohepatitis (NASH)
    Acharya, Eesha
    Lam, Robert
    Lim, Joseph
    Jain, Dhanpat
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 1106 - 1106
  • [8] NON-ALCOHOLIC STEATOHEPATITIS (NASH): US PAYER VALUE AND COVERAGE OF POTENTIAL NASH THERAPIES
    Ng-Haing, J.
    Loaiza, M.
    Alfaro, A.
    Sweeney, T.
    VALUE IN HEALTH, 2019, 22 : S151 - S151
  • [9] Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma
    Cuadrado, A
    Orive, A
    García-Suárez, C
    Domínguez, A
    Fernández-Escalante, JC
    Crespo, J
    Pons-Romero, F
    OBESITY SURGERY, 2005, 15 (03) : 442 - 446
  • [10] Effect of phlebotomy on non-alcoholic steatohepatitis (NASH).
    Nitecki, J
    Jackson, FW
    Allen, ML
    Farr, VL
    Jackson, FW
    GASTROENTEROLOGY, 2000, 118 (04) : A1474 - A1474
12345